Author(s): Akash Shelke, Someshwar Mankar, Mahesh Kolhe


DOI: 10.52711/2349-2988.2021.00021   

Address: Akash Shelke*, Someshwar Mankar, Mahesh Kolhe
Department of Quality Assurance Techniques, Prvara Rural College of Pharmacy, Pravaranagar, Tal- Rahta, Dist- Ahmednagar 413736, India.
*Corresponding Author

Published In:   Volume - 13,      Issue - 2,     Year - 2021

Apremilast is approved by USFDA in 2014. It is used in treatment of psoriatic arthritis and other conditions like atopic dermatitis and plaque psoriasis. It is act as an anti-inflammatory agent. It is phthalimide derivative and belongs to class 4 category of BCS system. It is a phosphodiesterase-4 (PDE-4) inhibitor. Analytical methods plays an important role to describe physico-chemical properties of drug. Due to low solubility and low permeability analytical method development and formulation becomes challenging. Till date, there are no standard test methods available to analyze Apremilast. So, a review of the analytical methods for apremilast is carried out. Here we discussed latest analytical methods for estimation of apremilast in bulk, Pharmaceuticals dosage form and in biological samples. In that we study methods like HPLC, UV-Visible spectroscopy, HPTLC, UPLC and mostly used hyphenated technique LC-MS. This review will be helpful for the researcher who is working on apremilast.

Cite this article:
Akash Shelke, Someshwar Mankar, Mahesh Kolhe. A Review on Analytical Methods for estimation of Apremelast in Bulk, Pharmaceutical Formulation and in Biological Samples. Research Journal of Science and Technology. 2021; 13(2):142-6. doi: 10.52711/2349-2988.2021.00021

Akash Shelke, Someshwar Mankar, Mahesh Kolhe. A Review on Analytical Methods for estimation of Apremelast in Bulk, Pharmaceutical Formulation and in Biological Samples. Research Journal of Science and Technology. 2021; 13(2):142-6. doi: 10.52711/2349-2988.2021.00021   Available on:

1.    European Medicines Agency; Assessment report; Procedure No. EMEA/H/C/003746; 2015
2.    Poole, R. M.; Ballantyne, A. D. Apremilast: First Global Approval. Drugs 2014, 74, 825–837. DOI: 10.1007/s40265-014-0218-4
3.    Zerilli, T.; Ocheretyaner, E. Apremilast (Otezla): A New Oral Treatment for Adults with Psoriasis and Psoriatic Arthritis. PT.2015, 40, 495–500.
4.    Monograph, P. Pr Otezlavr Apremilast. Celgene Corp. 2017, 1–55.
5.    An, I.; Harman, M.; I biloglu, I. Case Report Bullous Hemorrhagic Dermatosis Induced by Enoxaparin. Indian Dermatol. Online J 2018, 9, 347–350. DOI: 10.4103/idoj.IDOJ.
6.    Papp, K., Cather, JC., Rosoph, L., et al. Lancet, 2012. 380:738–746
7.    Schett, G., Sloan, VS., Stevens, RM., et al. Ther Adv Musculoskelet Dis, 2010. 2: 271–278.
8.    Paul, C., Cather, J., Gooderham, M., et al. Br J Dermatol, 2015.173:1387–1399.
9.    Siyuan, N.; Jing Junzhi, G. L. Stable Crystal Form II of the Apremilast, Not Containing Solvate, and Method of Its Receiving.RU Patent 000,2673,889, December 3, 2018.
10.    Monika, O.; Piotr, G.; Przemyslaw, S.; Dominika, P.; Marcin, S.; Arkadiusz, M. Crystalline Forms of Apremilast. EP 345,520, 9A1, March 3, 2019.
12.    Om, A.; Hill, D.; Feldman, S. R. Chapter 7, Apremilast. In Therapy for Severe Psoriasis. 2014, 12. DOI: 10.1016/j.chtm.2016.07.032.
13.    Thomas, J.; Jacob, S. E. Apremilast. J. Dermatol. Nurses Assoc.2017, 9, 154–156. DOI: 10.1097/JDN.0000000000000308
14.    Otezla (apremilast) prescribing information. Summit, New Jersey: Celgene Corp.; Dec, 2014.
15.    Food and Drug Administration Center for Drug Evaluation and Research. Nov, 2013. Application number: 205437Orig1s000: clinical pharmacology and biopharmaceutics review(s). Available at: Accessed July 6, 2015. [Ref list]
16.    Hoffmann M, Kumar G, Schafer P, Cedzik D, Capone L, Fong KL, Gu Z, Heller D, Feng H, Surapaneni S, Laskin O, Wu AXenobiotica, Disposition, metabolism and mass balance of [(14) C]apremilast following oral administration.. 2011 Dec; 41(12):1063-75
17.    Rajan V Rele and Patil SP, Reversed Phase High Performance Liquid Chromatography Method for Determination of Assay and Forced Degradation Study of Apremilast from Active Pharmaceutical Dosage Form, Journal of Chemical and Pharmaceutical Research, 2018, 10(7): 139-144
18.    Panchumarthy Ravisankar, Shaheem Sulthana, Kamma Harsha Sri, Development and Validation of a Stability-Indicating Reversed Phase Hplc Method for Determination of Apremilast in Bulk and Pharmaceutical Dosage Form, Scholars Research Library Der Pharmacia Lettre, 2017, 9 [6]:63-73
19.    Mukthinuthalapati Mathrusri Annapurna, Debi Prasad Pradhan, Malineni Sushmitha. A new Stability indicating RP-HPLC method for the determination of Apremilast-An Antirheumatic drug. Research J. Pharm. and Tech. 2017; 10(4): 1160-1164. doi: 10.5958/0974-360X.2017.00209.8
20.    Rina Mohan Sonawane, Rutuja Prabhakar Sonare, Snehal Ganpat Tekawade and Dr. Ashok Pandurang Pingle, chromatographic method development and validation of assay of apremilast in bulk and tablet dosage form, ejbps, 2018, Volume 5, Issue 8, 412-417.
21.    Ajit Anerao, Vihar Telange, Nitin Bondre., Satish John., Thaksen Gadhave and Nitin Pradhan, stability-indicating related substances method of apremilast by hplc and synthesis and chracterization of related impurities using mass and nmr spectroscopy, International Journal of Current Medical and Pharmaceutical Research, Vol. 3, Issue, 02, pp.1378-1385, February, 2017
22.    Bhardwaj SK, Dwivedia K, Agarwala DD. A review: HPLC method development and validation. International Journal of Analytical and Bioanalytical Chemistry. 2015;5(4):76-81
23.    Chen, L. G.; Wang, Z.; Wang, S.; Li, T.; Pan, Y.; Lai, X. Determination of Apremilast in Rat Plasma by UPLC-MS-MSand Its Application to a Pharmacokinetic Study. J. Chromatogr. Sci. 2016, 54, 1336–1340. DOI: 10.1093/chromsci/bmw072
24.    Hemaraj R. Patil, Dr. S. T. Patil, V. H. Jain And Dr. S. P. Pawar. Development And Validation of UV-Spectrophotometric and HPLC Method for Apremilast In Bulk and Tablet Dosage Form. Ejpmr, 2019,6(8), 233-239
25.    Lonkar NA, Dole MN, Sawant SD. Development and validation of UV spectrophotometric method for the estimation of apremilast in bulk form by absorbance maxima method. World J Pharm Pharm Sci. 2017 Apr 22; 6(7):758-66
26.    Intwala JK, Doshi DB. development and validation of sophisticated analytical method for the estimation of apremilast. Pharma Science Monitor. 2017 Apr 1;8(2).
27.    Chakravarthy AV, Sailaja BB, Kumar PA. Method development and validation of ultraviolet-visible spectroscopic method for the estimation of assay of sugammadex sodium, Apremilast, riociguat, and vorapaxar sulfate drugs in active pharmaceutical ingredient form. Asian J Pharm Clin Res. 2017;10(2):241-50.
28.    Bhole RP, Naksakhare SR, Bonde CG. A Stability Indicating HPTLC Method for Apremilast and Identification of degradation products using MS/MS. Journal of Pharmaceutical Sciences and Research. 2019 May 1;11(5):1861-9.
29.    Chaudhari SR, Shirkhedkar AA. Application of Box-Behnken Design for Validation of High Performance Thin-Layer Chromatography/Densitometry Method for Robustness Determination of Apremilast in Bulk and inhouse Tablets. Pharmaceutical Methods. 2018 Jan 1;9(1).
30.    Pushpa Latha E, Sailaja B. Bioanalytical method development and validation by HPLC: a review. J Appl Pharm. 2014 Dec; 1:1-9.
31.    Abdul Rahman MM, Kalyani Rupnawar, Madhuri A. Nagras And Supriya A. Unavane. A Review on Bioanalytical Method Development, Validation and Techniques Used for Pharmacokinetic Studies Using LCMS/MS, Contemporary Investigations and Observations in Pharmacy, 2012, 1(2), 63-71.
32.    Taleuzzaman M, Ali S, Gilani SJ, Imam SS and Hafeez A, Ultra Performance Liquid Chromatography (UPLC) - A Review, Austin J Anal Pharm Chem. 2015; 2(6): 1056.
33.    Iqbal M, Ezzeldin E, Al-Rashood ST, Imam F, Al-Rashood KA. Determination of apremilast in rat plasma by UPLC–MS/MS in ESI-negative mode to avoid adduct ions formation. Bioanalysis. 2016 Jul;8(14):1499-508.
34.    Anwer, M. K.; Mohammad, M.; Ezzeldin, E.; Fatima, F.; Alalaiwe, A.; Iqbal, M. Preparation of Sustained Release Apremilast-Loaded PLGAlga Nanoparticles: In Vitro Characterization and in Vivo Pharmacokinetic Study in Rats.IJN. 2019, 14, 1587–1595.
35.    Hoffmann, M.; Kumar, G.; Schafer, P.; Cedzik, D.; Capone, L.;Fong, K.-L.; Gu, Z.; Heller, D.; Feng, H.; Surapaneni, S.; et al. Disposition, Metabolism and Mass Balance of [14C]Apremilast following Oral Administration. Xenobiotica 2011, 41,1063–1075.
36.    Xiong, K.; Ma, X.; Cao, N.; Liu, L.; Sun, L.; Zou, Q.; Wei, P. Identification, Characterization and HPLC Quantification of Impurities in Apremilast. Anal. Methods 2016, 8, 1889–1897.
37.    Tang, M.; Hu, P.; Huang, S.; Zheng, Q.; Yu, H.; He, Y. Development of an Extended-Release Formulation for Apremilast and a Level A in Vitro–in Vivo Correlation Studyin Beagle Dogs. Chem. Pharm. Bull. 2016, 64, 1607–1615

Recomonded Articles:

Author(s): Rutuja S Nalkar, Suhas S Siddheshwar, Mahesh H Kolhe

DOI: 10.52711/2349-2988.2021.00036         Access: Open Access Read More

Author(s): Leena Sahu, Amit Roy, Trilochan Satapathy

DOI:         Access: Open Access Read More

Author(s): Premjit S Nannaware, Suhas S. Siddheshwar, M.H. Kolhe

DOI: 10.52711/2349-2988.2021.00019         Access: Open Access Read More

Author(s): Sachin Aglawe, Amol Gayke, Prasad Murade, Prashant Swami, Pramod Game, Pratik Kadam, Shubham Kanawade, Yogesh Garud

DOI: 10.5958/2349-2988.2019.00040.8         Access: Open Access Read More

Author(s): Mohini Shelke, Shraddha Parjane, S. D Mankar, S. S. Siddheshwar

DOI: 10.52711/2349-2988.2021.00023         Access: Open Access Read More

Author(s): Ashwani Awasthi, Shashi Kant Tripathi, Ashok Kumar Tiwari

DOI: 10.5958/2349-2988.2018.00019.0         Access: Open Access Read More

Author(s): Anuja Uddhav Deokar, Dr Suhas Siddheshwar, Sudarshan. B. Kakad

DOI: 10.5958/2349-2988.2020.00004.2         Access: Open Access Read More

Author(s): RS Jadhav, PN Kendre, MH Kolhe, S N Lateef, SM Shelke, RK Godge

DOI:         Access: Open Access Read More

Author(s): Lal Babu Prasad Yadav, Ajay Singh

DOI: 10.5958/2349-2988.2017.00046.8         Access: Open Access Read More

Author(s): A.K. Meena, Kiran Sharma, Vikas Jain, Bhavana Pal, Ajit K., Uttam Singh, R. Singh , M.M. Rao

DOI:         Access: Open Access Read More

Author(s): Rupali Tambe, Someshwar Mankar, Santosh Dighe

DOI: 10.5958/2349-2988.2020.00003.0         Access: Open Access Read More

Research Journal of Science and Technology (RJST) is an international, peer-reviewed journal, devoted to science and technology...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2349-2988 

Recent Articles